IPO Date: May 14 to May 16 2025
Listing Date: May 21 2025
a.Capital expenditure towards purchase of new equipment/machineries, etc.b.Capital expenditure towards upgradation of existing manufacturing facility;c.Repayment/prepayment of certain borrowings availed by our Company;d.Funding working capital requirements; ande.General Corporate Purpose
29 Xcelon Ind Park 1 B/h, Intas Pharmaceuticals Vasna Chacharvadi, Sanand
Ahmedabad
Gujarat
382213
9714882929
compliance@accretionpharma.com
http://www.accretionpharma.com
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
In Compliance with Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, SRF has informed that it attached Business Responsibility and Sustainability Report for FY 2025-26 of the company. The Business Responsibility and Sustainability Report forms an integral part of the Annual Report FY 2025-26 which can also be accessed at the company’s website at: www.srf.com.
The above information is a part of company’s filings submitted to BSE.
Manraj Housing Finance has submitted the documents required by the exchange the raising the discrepancies by Exchange dated 29th May, 2026. In this connection, it has enclosed the following: 1. Approved the Audited Financial Results for the quarter and year ended 31st March, 2026. A copy of the same is enclosed. 2. Approved the Audit Report submitted by Ratan Chandak & Co LLP Chartered Accountants, Statutory Auditors of the company. A copy of the same is enclosed. 3. Statement on Impact of Audit Qualification for Year Ended - March 2026.
The above information is a part of company’s filings submitted to BSE.
No Records Found
The issue size of Accretion Pharmaceuticals Ltd. IPO is ₹26.25 - 27.62 crore.
The Accretion Pharmaceuticals Ltd. IPO opens for subscription on 2025-05-14 and closes on 2025-05-16.
The price range of Accretion Pharmaceuticals Ltd. IPO is ₹96.00 to ₹101.00.
The lot size of Accretion Pharmaceuticals Ltd. IPO is 1200 shares.
The registrar of Accretion Pharmaceuticals Ltd. IPO is K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.).
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.